Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

BR 8003

Next Previous
Search
Drug Profile

BR 8003

Alternative Names: BR 8003; BVN 003; Hepatitis A vaccine - Boryung Pharmaceutical; Inactivated hepatitis A vaccine - Boryung Pharmaceutical

Latest Information Update: 06 Feb 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Boryung Pharmaceutical
  • Class Hepatitis A vaccines; Vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Hepatitis A

Most Recent Events

  • 23 Jan 2025 Discontinued - Phase-III for Hepatitis A (In adolescents, In the elderly, Prevention, In adults) in South Korea (IM)
  • 23 Jan 2025 Discontinued - Phase-III for Hepatitis A (In infants, Prevention) in South Korea (IM)
  • 14 Nov 2022 Boryung Biopharma plans a phase III trial for Hepatitis A (In children, In adolescents, Prevention) in Thailand and South Korea (IM) (NCT05613127)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top